215 related articles for article (PubMed ID: 31692151)
21. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
22. Older patients' perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital.
Tegegn HG; Tefera YG; Erku DA; Haile KT; Abebe TB; Chekol F; Azanaw Y; Ayele AA
BMJ Open; 2018 Apr; 8(4):e020590. PubMed ID: 29678983
[TBL] [Abstract][Full Text] [Related]
23. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
Trials; 2016 Jan; 17():57. PubMed ID: 26822311
[TBL] [Abstract][Full Text] [Related]
24. Medicine optimization strategy in an acute geriatric unit: The pharmacist in the geriatric team.
Gutiérrez-Valencia M; Izquierdo M; Beobide-Telleria I; Ferro-Uriguen A; Alonso-Renedo J; Casas-Herrero Á; Martínez-Velilla N
Geriatr Gerontol Int; 2019 Jun; 19(6):530-536. PubMed ID: 30950148
[TBL] [Abstract][Full Text] [Related]
25. Geriatric Polypharmacy: Two Physicians' Personal Perspectives.
Chen Z; Buonanno A
Clin Geriatr Med; 2017 May; 33(2):283-288. PubMed ID: 28364996
[TBL] [Abstract][Full Text] [Related]
26. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
[TBL] [Abstract][Full Text] [Related]
27. Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians.
Kouladjian O'Donnell L; Reeve E; Cumming A; Scott IA; Hilmer SN
Intern Med J; 2021 Jan; 51(1):111-115. PubMed ID: 33572018
[TBL] [Abstract][Full Text] [Related]
28. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S
BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397
[TBL] [Abstract][Full Text] [Related]
29. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
Palagyi A; Keay L; Harper J; Potter J; Lindley RI
BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
[TBL] [Abstract][Full Text] [Related]
30. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
31. Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review.
Brokaar EJ; van den Bos F; Visser LE; Portielje JEA
Am J Hosp Palliat Care; 2022 Jan; 39(1):86-100. PubMed ID: 33739162
[TBL] [Abstract][Full Text] [Related]
32. [Polypharmacy and deprescribing in cardiology].
Bobbio M
G Ital Cardiol (Rome); 2020 Oct; 21(10):801-806. PubMed ID: 32968317
[TBL] [Abstract][Full Text] [Related]
33. Medication-related problems in older people: how to optimise medication management.
Wong CW
Hong Kong Med J; 2020 Dec; 26(6):510-519. PubMed ID: 33323538
[TBL] [Abstract][Full Text] [Related]
34. A medication review and deprescribing method for hospitalised older patients receiving multiple medications.
McKean M; Pillans P; Scott IA
Intern Med J; 2016 Jan; 46(1):35-42. PubMed ID: 26387783
[TBL] [Abstract][Full Text] [Related]
35. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.
Galazzi A; Lusignani M; Chiarelli MT; Mannucci PM; Franchi C; Tettamanti M; Reeve E; Nobili A
Int J Clin Pharm; 2016 Apr; 38(2):454-61. PubMed ID: 26951120
[TBL] [Abstract][Full Text] [Related]
36. CE: Mitigating the Dangers of Polypharmacy in Community-Dwelling Older Adults.
Gabauer J
Am J Nurs; 2020 Feb; 120(2):36-42. PubMed ID: 31977416
[TBL] [Abstract][Full Text] [Related]
37. Frailty, polypharmacy and deprescribing.
Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
[TBL] [Abstract][Full Text] [Related]
38. Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases: cluster randomised controlled trial.
Rieckert A; Reeves D; Altiner A; Drewelow E; Esmail A; Flamm M; Hann M; Johansson T; Klaassen-Mielke R; Kunnamo I; Löffler C; Piccoliori G; Sommerauer C; Trampisch US; Vögele A; Woodham A; Sönnichsen A
BMJ; 2020 Jun; 369():m1822. PubMed ID: 32554566
[TBL] [Abstract][Full Text] [Related]
39. Prescribing or deprescribing in older persons: what are the real‑life concerns in geriatric practice?
Bień B; Bień-Barkowska K
Pol Arch Intern Med; 2018 Apr; 128(4):200-208. PubMed ID: 29442099
[TBL] [Abstract][Full Text] [Related]
40. New horizons in deprescribing for older people.
Woodford HJ; Fisher J
Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
